Ixekizumab in the Treatment of Bullous Pemphigoid

NCT03099538 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Bullous Pemphigoid
Pemphigoid

Interventions

DRUG: Ixekizumab

Sponsor

Mayo Clinic

Collaborators

[object Object]